The International Association for the Study of Lung Cancer (IASLC) and The Lung Cancer Research Foundation (LCRF) have announced that a project led by David A. Barbie, MD, of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Center, is the first to receive the IASLC LCRF Team Science Research Grant on the Next Step in the Cure of Oncogene-Driven Lung Cancers Award. ...
Lung Cancers Today
A new medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and more.
Advertisement
For patients with Schlafen 11-positive ES-SCLC, atezolizumab plus talazoparib showed an PFS improvement after chemotherapy.
Deborah Brown shares key findings from the recently released seventh annual "State of Lung Cancer" report.
Researchers Analyze Olaparib, Pemetrexed as Maintenance Therapy Additions to Pembrolizumab for NSCLC
Pembrolizumab plus maintenance olaparib was not shown to improve survival in patients with metastatic nonsquamous NSCLC.
The campaign kicked off on November 1 to coincide with Lung Cancer Awareness Month.
Durvalumab does not improve overall survival compared to chemotherapy when used as a first-line treatment for mNSCLC.
The updated analysis was presented at the Society for Immunotherapy in Cancer 2024 Annual Meeting.
Deborah Brown shares how the American Lung Association and its LUNG FORCE initiative are raising awareness this month.
Officials Provide Update on Datopotamab Deruxtecan Biologics License Application for NSCLC Treatment
A prior BLA has been voluntarily withdrawn and a new BLA has been submitted for US accelerated approval.
The real-world study is the first to provide an overview of EGFR mutations and subtype prevalence in patients with NSCLC.
Dr. Studts discusses why Lung Cancer Awareness Month is a critical time to inspire action, engagement, and hope.
Advertisement
Roundtable Discussions on Lung Cancer
Expert Interviews on Lung Cancer
Conference Coverage
Find the latest news and updates on lung cancer from the ESMO Congress 2024.
Find the latest updates on lung cancer treatment and research from the IASLC 2024 World Conference on Lung Cancer.
Find the latest updates on lung cancer treatment and research from the 2024 ASCO Annual Meeting.
Our editors detail the latest data and innovations in the lung cancer space presented at ATS 2024.
Our editors deliver in-depth coverage of NACLC 2023, a premier event offering the latest data on lung cancer advancements.
Our editors provide comprehensive coverage of ESMO Congress 2023, with a focus on lung cancer.
Our editors detail the latest data and innovations in the lung cancer space, as presented at WCLC 2023.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.